Podcast

Pharmacy Focus: Oncology Edition - What You Missed at ASCO 2022

This month, we reviewed key topics and interviews from the American Society of Clinical Oncology 2022 Annual Meeting.

This month, we reviewed key topics and interviews from the American Society of Clinical Oncology 2022 Annual Meeting. Experts discussed pharmacists' roles in clinical trial enrollment, CAR T therapies for multiple myeloma, new data from the ATHENA-MONO trial in ovarian cancer, and more.

Related Videos
Patient receiving cancer care from provider -- Image credit: Rido | stock.adobe.com
Patient taking prescription medicine -- Image credit: Rawpixel.com | stock.adobe.com
Pharmacist talking to a patient with cancer
CAR T cell 3d rendering in oncology
Related Content
Microscopic view of high grade follicular lymphoma with marginal zone differentiation
October 4th 2024

Acalabrutinib-Rituximab Combination Effective in Relapsed/Refractory, Treatment-Naive Follicular Lymphoma

Luke Halpern, Assistant Editor
Pharmacy Focus - Oncology Edition: Advancing Brain Cancer Research and Treatment
September 26th 2024

Pharmacy Focus - Oncology Edition: Advancing Brain Cancer Research and Treatment

Colorectal cancer awareness concept.
October 4th 2024

Cologuard Plus Receives FDA Approval For Non-Invasive Colorectal Cancer Screening

Luke Halpern, Assistant Editor
Public Health Matters podcast logo
September 19th 2024

Public Health Matters: The Difference Between Misinformation and Disinformation, and How Information Can Inform Evidence-Based Decisions

Image Credit: © NeuroGraphix Studio - stock.adobe.com
October 3rd 2024

Study Findings Suggest Use of Fedratinib as Treatment in the Second Line for Myelofibrosis

Alexandra Gerlach, Associate Editor
Eculizumab and Other Therapies for the Treatment of High-Risk Transplant-Associated Thrombotic Microangiopathy
October 3rd 2024

Eculizumab and Other Therapies for the Treatment of High-Risk Transplant-Associated Thrombotic Microangiopathy

Hayden Mitteer, PharmD Candidate